blank
blank

ERDERA Launches the 2025 Joint Transnational Call for Proposals on Rare Disease Therapies

ERDERA Launches the 2025 Joint Transnational Call for Proposals on Rare Disease Therapies

The European Rare Diseases Research Alliance (ERDERA) is delighted to announce the official launch of its 2025 Joint Transnational Call (JTC) for Proposals as of today, 10 December 2024. This eagerly anticipated call invites research teams across Europe and internationally to collaborate on cutting-edge projects aimed at“Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.”

See all the details of the official call here.

Application Timeline

The JTC 2025 will follow a two-stage submission process:

  • 13 February 2025: Pre-proposal submission deadline.
  • 9 July 2025: Full proposals submission deadline. Funding decisions are expected by December 2025.

Interested applicants can join an informationalwebinar on 17 December 2024, providing valuable guidance on preparing submissions.

For more information, contact the Joint Call Secretariat atSelteneErkrankungen@dlr.de or reach out to the relevant national contact point.

Stay informed with the latest updates from ERDERA by subscribing to our newsletter and following us on social media.

News & Updates

You might also be interested in

P.Sudara - Undiagnosed Day 2026

In Gdańsk, Undiagnosed Day showed why diagnosis is both a scientific and a human challenge

Bringing clinicians, researchers, patient representatives and families together, the event examined how shorter diagnostic pathways depend not only on better tests, but on shared expertise, structured phenotyping and patient-centred support.
ERDERA and european genomic data infrastructure

Strategic collaboration between GDI and ERDERA

ERDERA and the European Genomic Data Infrastructure have signed a Memorandum of Understanding to strengthen collaboration on secure cross-border access to genomic, clinical and other health-related data, supporting rare disease research and the development of personalised medicine in Europe.
Bojana Mirosavljevic

“Patients are the glue that keeps all other stakeholders together—without them, the system simply does not exist”

ERDERA interviews Bojana Mirosavljevic, scientist and founder of the Život/Life association in Serbia; and one of the country’s leading voices rare disease patient advocacy.
Radka Kaneva and Petia Stratieva, Sofia, March 2026

“National Mirror Groups are essentially a bridge — bringing European developments, standards and opportunities to clinicians and researchers.”

ERDERA interviews Prof. Radka Kaneva and Dr Petia Stratieva, two leading members of Bulgaria’s National Mirror Group (NMG), to explore how the country is working to align its rare disease ecosystem with European developments.

ERDERA's

search form